[1]
Karachalios GN, Donas G. Sulindac in the treatment of acute gout arthritis. International journal of tissue reactions. 1982:4(4):297-9
[PubMed PMID: 7169301]
[2]
Gurpinar E, Grizzle WE, Piazza GA. COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs. Frontiers in oncology. 2013:3():181. doi: 10.3389/fonc.2013.00181. Epub 2013 Jul 11
[PubMed PMID: 23875171]
[3]
Herzig D, Hardiman K, Weiser M, You N, Paquette I, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes. Diseases of the colon and rectum. 2017 Sep:60(9):881-894. doi: 10.1097/DCR.0000000000000912. Epub
[PubMed PMID: 28796726]
Level 1 (high-level) evidence
[5]
Yin T, Wang G, Ye T, Wang Y. Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator. Scientific reports. 2016 Jan 18:6():19534. doi: 10.1038/srep19534. Epub 2016 Jan 18
[PubMed PMID: 26777116]
[6]
Strong HA, Warner NJ, Renwick AG, George CF. Sulindac metabolism: the importance of an intact colon. Clinical pharmacology and therapeutics. 1985 Oct:38(4):387-93
[PubMed PMID: 4042521]
[7]
Lampela ES, Nuutinen LH, Ala-Kokko TI, Parikka RM, Laitinen RS, Jouppila PI, Vähäkangas KH. Placental transfer of sulindac, sulindac sulfide, and indomethacin in a human placental perfusion model. American journal of obstetrics and gynecology. 1999 Jan:180(1 Pt 1):174-80
[PubMed PMID: 9914600]
[8]
Modi JP, Prentice H, Wu JY. Sulindac for stroke treatment: neuroprotective mechanism and therapy. Neural regeneration research. 2014 Dec 1:9(23):2023-5. doi: 10.4103/1673-5374.147919. Epub
[PubMed PMID: 25657710]
[9]
Baker M, Perazella MA. NSAIDs in CKD: Are They Safe? American journal of kidney diseases : the official journal of the National Kidney Foundation. 2020 Oct:76(4):546-557. doi: 10.1053/j.ajkd.2020.03.023. Epub 2020 May 30
[PubMed PMID: 32479922]
[10]
Brown BL, Johnson JH, Hearron MS. Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis. The American journal of medicine. 1986 Mar 24:80(3A):112-7
[PubMed PMID: 3515919]
Level 1 (high-level) evidence
[11]
Sitar DS, Owen JA, MacDougall B, Hunter T, Mitenko PA. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac. Clinical pharmacology and therapeutics. 1985 Aug:38(2):228-34
[PubMed PMID: 4017423]
[12]
Siegmeth W, Hartmann G, Sieberer W. [Sulindac in the treatment of soft tissue rheumatism (periarthropathy of the hip and shoulder (author's transl)]. Wiener medizinische Wochenschrift (1946). 1980 Jul 31:130(13-14):492-5
[PubMed PMID: 7424040]
[15]
Dathe K, Hultzsch S, Pritchard LW, Schaefer C. Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature review. European journal of clinical pharmacology. 2019 Oct:75(10):1347-1353. doi: 10.1007/s00228-019-02712-2. Epub 2019 Jul 4
[PubMed PMID: 31273431]
[16]
Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis & rheumatology (Hoboken, N.J.). 2020 Apr:72(4):529-556. doi: 10.1002/art.41191. Epub 2020 Feb 23
[PubMed PMID: 32090480]
[17]
Martin E, Vickers B, Landau R, Reece-Stremtan S. ABM Clinical Protocol #28, Peripartum Analgesia and Anesthesia for the Breastfeeding Mother. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine. 2018 Apr:13(3):164-171. doi: 10.1089/bfm.2018.29087.ejm. Epub 2018 Mar 29
[PubMed PMID: 29595994]
[18]
By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023 Jul:71(7):2052-2081. doi: 10.1111/jgs.18372. Epub 2023 May 4
[PubMed PMID: 37139824]
[19]
Bjorkman D. Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus. The American journal of medicine. 1998 Nov 2:105(5A):17S-21S
[PubMed PMID: 9855171]
[20]
Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging and disease. 2018 Feb:9(1):143-150. doi: 10.14336/AD.2017.0306. Epub 2018 Feb 1
[PubMed PMID: 29392089]
[21]
Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, González-Aveledo L. Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update. Pharmaceuticals (Basel, Switzerland). 2010 Jan 5:3(1):10-18
[PubMed PMID: 27713240]
[22]
Mockenhaupt M, Kelly JP, Kaufman D, Stern RS, SCAR Study Group. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective. The Journal of rheumatology. 2003 Oct:30(10):2234-40
[PubMed PMID: 14528522]
Level 3 (low-level) evidence
[23]
Camin RM, Cols M, Chevarria JL, Osuna RG, Carreras M, Lisbona JM, Coderch J. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: "The Triple Whammy". Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2015:35(2):197-206. doi: 10.1016/j.nefro.2015.05.021. Epub 2015 Jun 23
[PubMed PMID: 26300514]
[24]
El-Yazbi AF, Eid AH, El-Mas MM. Cardiovascular and renal interactions between cyclosporine and NSAIDs: Underlying mechanisms and clinical relevance. Pharmacological research. 2018 Mar:129():251-261. doi: 10.1016/j.phrs.2017.11.029. Epub 2017 Nov 26
[PubMed PMID: 29183768]
[25]
Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ (Clinical research ed.). 2013 Jan 8:346():e8525. doi: 10.1136/bmj.e8525. Epub 2013 Jan 8
[PubMed PMID: 23299844]
Level 2 (mid-level) evidence
[26]
Uwai Y, Saito H, Inui K. Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter. European journal of pharmacology. 2000 Dec 1:409(1):31-6
[PubMed PMID: 11099697]
[27]
Clinard F, Sgro C, Bardou M, Hillon P, Dumas M, Kreft-Jais C, Escousse A, Bonithon-Kopp C. Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database. European journal of clinical pharmacology. 2004 Jun:60(4):279-83
[PubMed PMID: 15103437]
Level 3 (low-level) evidence
[28]
Villa Zapata L, Hansten PD, Panic J, Horn JR, Boyce RD, Gephart S, Subbian V, Romero A, Malone DC. Risk of Bleeding with Exposure to Warfarin and Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review and Meta-Analysis. Thrombosis and haemostasis. 2020 Jul:120(7):1066-1074. doi: 10.1055/s-0040-1710592. Epub 2020 May 26
[PubMed PMID: 32455439]
Level 1 (high-level) evidence
[29]
Ungprasert P, Cheungpasitporn W, Crowson CS, Matteson EL. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. European journal of internal medicine. 2015 May:26(4):285-91. doi: 10.1016/j.ejim.2015.03.008. Epub 2015 Apr 8
[PubMed PMID: 25862494]
Level 1 (high-level) evidence
[30]
Eriksson LO, Beermann B, Kallner M. Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure. Clinical pharmacology and therapeutics. 1987 Dec:42(6):646-54
[PubMed PMID: 3319349]
[31]
Wood LJ, Mundo F, Searle J, Powell LW. Sulindac hepatotoxicity: effects of acute and chronic exposure. Australian and New Zealand journal of medicine. 1985 Aug:15(4):397-401
[PubMed PMID: 3866535]
[32]
Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annual review of pharmacology and toxicology. 1993:33():435-65
[PubMed PMID: 8494347]
[33]
Goodwin SD, Glenny RW. Nonsteroidal anti-inflammatory drug-associated pulmonary infiltrates with eosinophilia. Review of the literature and Food and Drug Administration Adverse Drug Reaction reports. Archives of internal medicine. 1992 Jul:152(7):1521-4
[PubMed PMID: 1627033]
[34]
Lione A, Scialli AR. The developmental toxicity of indomethacin and sulindac. Reproductive toxicology (Elmsford, N.Y.). 1995 Jan-Feb:9(1):7-20
[PubMed PMID: 8520134]
[35]
Angeles ML, Reid ME, Yacob UA, Cash KL, Fetten JV. Sulindac-induced immune hemolytic anemia. Transfusion. 1994 Mar:34(3):255-8
[PubMed PMID: 8146901]
[37]
Schoenfeld A, Bar Y, Merlob P, Ovadia Y. NSAIDs: maternal and fetal considerations. American journal of reproductive immunology (New York, N.Y. : 1989). 1992 Oct-Dec:28(3-4):141-7
[PubMed PMID: 1285865]
[38]
Lapane KL, Spooner JJ, Mucha L, Straus WL. Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care. Journal of the American Geriatrics Society. 2001 May:49(5):577-84
[PubMed PMID: 11380750]
[39]
Vaughn JL, Shah KV, Ghossein MM, Meyer WL, Kirkpatrick RB. Acute kidney injury, hyperbilirubinemia, and ischemic skin necrosis due to massive sulindac overdose. Current drug safety. 2015:10(2):190-2
[PubMed PMID: 25986039]
[40]
Gross GE. Granulocytosis and a sulindac overdose. Annals of internal medicine. 1982 Jun:96(6 Pt 1):793-4
[PubMed PMID: 7091952]
[41]
Bear MD, Bartlett D, Evans P. Pharmacist Counseling and the Use of Nonsteroidal Anti-Inflammatory Drugs by Older Adults. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 2017 Mar 1:32(3):161-168. doi: 10.4140/TCP.n.2017.161. Epub
[PubMed PMID: 28270271]